Matches in SemOpenAlex for { <https://semopenalex.org/work/W2128241750> ?p ?o ?g. }
- W2128241750 endingPage "216" @default.
- W2128241750 startingPage "206" @default.
- W2128241750 abstract "Treatment of non-small cell lung cancer (NSCLC) with cisplatin has a level of antitumor activity still modest. We have shown previously that MKP1/DUSP1 inhibits cisplatin-induced apoptosis in NSCLC cells and is overexpressed in tumors from most patients with stage I–II NSCLC. Here, using different NSCLC cell lines we found that MKP1 and NF-κB are differentially expressed. We studied whether targeting MKP1, NF-κB or both affects cisplatin-induced cell death. MKP1 is expressed in H460 and H727 cells. H727 and H1299 cells showed constitutive phosphorylation of Akt and increased NF-κB activity than did H460 cells. H460-MKP1-siRNA-expressing cells (but not H727-MKP1-siRNA or H1299-MKP1-siRNA cells) exhibit a marked increase in cisplatin response compared with parental cells. Treatment with the PI3K inhibitor LY294002 or the NF-κB inhibitor BAY11-7082 enhanced cisplatin antitumor activity in parental H1299 cells but only weakly affected responses of H727 and H460 cells. MKP1-siRNA expression enhanced the chemosensitization effect of LY294002 and BAY11-7082 on H727 and H460 cells. Additionally, NSCLC cell lines with higher NF-κB-constitutive activation were the most sensitive to PS-341 (Bortezomib), a non-specific NF-κB inhibitor. This finding suggests the proteasome as a suitable strategy in treating NSCLC tumors with high constitutive NF-κB activity. Altogether, these results showed that either an activated PI3K/Akt/NF-κB pathway and/or high MKP1 was linked to reduced sensitivity to cisplatin in NSCLC cells. Inhibition of NF-κB or PI3K potently enhanced cisplatin cytotoxicity in cells with endogenous or genetically induced low MKP1 levels. These findings support the potential improvement in cisplatin responses by co-targeting NF-κB or Akt and MKP1." @default.
- W2128241750 created "2016-06-24" @default.
- W2128241750 creator A5006519575 @default.
- W2128241750 creator A5006908125 @default.
- W2128241750 creator A5016784014 @default.
- W2128241750 creator A5018597732 @default.
- W2128241750 creator A5026127785 @default.
- W2128241750 creator A5028089976 @default.
- W2128241750 creator A5029048001 @default.
- W2128241750 creator A5041043875 @default.
- W2128241750 creator A5044837065 @default.
- W2128241750 creator A5045101760 @default.
- W2128241750 creator A5064401001 @default.
- W2128241750 creator A5070235024 @default.
- W2128241750 creator A5071808636 @default.
- W2128241750 creator A5079647211 @default.
- W2128241750 creator A5085862698 @default.
- W2128241750 creator A5087119241 @default.
- W2128241750 date "2009-12-01" @default.
- W2128241750 modified "2023-10-17" @default.
- W2128241750 title "MKP1 repression is required for the chemosensitizing effects of NF-κB and PI3K inhibitors to cisplatin in non-small cell lung cancer" @default.
- W2128241750 cites W1495346616 @default.
- W2128241750 cites W1574327030 @default.
- W2128241750 cites W1968807700 @default.
- W2128241750 cites W1973577899 @default.
- W2128241750 cites W1976715882 @default.
- W2128241750 cites W1979695251 @default.
- W2128241750 cites W1992889151 @default.
- W2128241750 cites W2017285418 @default.
- W2128241750 cites W2021573815 @default.
- W2128241750 cites W2024306318 @default.
- W2128241750 cites W2037915962 @default.
- W2128241750 cites W2038959355 @default.
- W2128241750 cites W2047826668 @default.
- W2128241750 cites W2049406640 @default.
- W2128241750 cites W2051994734 @default.
- W2128241750 cites W2060259534 @default.
- W2128241750 cites W2070853191 @default.
- W2128241750 cites W2074150439 @default.
- W2128241750 cites W2075554815 @default.
- W2128241750 cites W2078707053 @default.
- W2128241750 cites W2090507360 @default.
- W2128241750 cites W2097767970 @default.
- W2128241750 cites W2101045201 @default.
- W2128241750 cites W2110096065 @default.
- W2128241750 cites W2110823811 @default.
- W2128241750 cites W2116877478 @default.
- W2128241750 cites W2127281537 @default.
- W2128241750 cites W2131290484 @default.
- W2128241750 cites W2136951601 @default.
- W2128241750 cites W2150033965 @default.
- W2128241750 cites W2156633409 @default.
- W2128241750 cites W2159722075 @default.
- W2128241750 cites W2166608001 @default.
- W2128241750 cites W2167085364 @default.
- W2128241750 cites W2168091755 @default.
- W2128241750 cites W2169724245 @default.
- W2128241750 cites W2388163742 @default.
- W2128241750 cites W95988660 @default.
- W2128241750 doi "https://doi.org/10.1016/j.canlet.2009.05.029" @default.
- W2128241750 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19553005" @default.
- W2128241750 hasPublicationYear "2009" @default.
- W2128241750 type Work @default.
- W2128241750 sameAs 2128241750 @default.
- W2128241750 citedByCount "21" @default.
- W2128241750 countsByYear W21282417502012 @default.
- W2128241750 countsByYear W21282417502013 @default.
- W2128241750 countsByYear W21282417502014 @default.
- W2128241750 countsByYear W21282417502016 @default.
- W2128241750 countsByYear W21282417502017 @default.
- W2128241750 countsByYear W21282417502018 @default.
- W2128241750 countsByYear W21282417502021 @default.
- W2128241750 countsByYear W21282417502023 @default.
- W2128241750 crossrefType "journal-article" @default.
- W2128241750 hasAuthorship W2128241750A5006519575 @default.
- W2128241750 hasAuthorship W2128241750A5006908125 @default.
- W2128241750 hasAuthorship W2128241750A5016784014 @default.
- W2128241750 hasAuthorship W2128241750A5018597732 @default.
- W2128241750 hasAuthorship W2128241750A5026127785 @default.
- W2128241750 hasAuthorship W2128241750A5028089976 @default.
- W2128241750 hasAuthorship W2128241750A5029048001 @default.
- W2128241750 hasAuthorship W2128241750A5041043875 @default.
- W2128241750 hasAuthorship W2128241750A5044837065 @default.
- W2128241750 hasAuthorship W2128241750A5045101760 @default.
- W2128241750 hasAuthorship W2128241750A5064401001 @default.
- W2128241750 hasAuthorship W2128241750A5070235024 @default.
- W2128241750 hasAuthorship W2128241750A5071808636 @default.
- W2128241750 hasAuthorship W2128241750A5079647211 @default.
- W2128241750 hasAuthorship W2128241750A5085862698 @default.
- W2128241750 hasAuthorship W2128241750A5087119241 @default.
- W2128241750 hasConcept C2776694085 @default.
- W2128241750 hasConcept C2776912716 @default.
- W2128241750 hasConcept C2777730290 @default.
- W2128241750 hasConcept C2778239845 @default.
- W2128241750 hasConcept C502942594 @default.
- W2128241750 hasConcept C54355233 @default.
- W2128241750 hasConcept C62478195 @default.
- W2128241750 hasConcept C75217442 @default.